"Amused" (cool trading name by the way).
I am just not sure anyone actually needs to work with CYP. There are a bunch of other ways to achieve the same outcome. Their IP is really limited and almost unforceable. I am not saying they are a "quack" company (not at all) but I am just not sure there is an exit.
The market cap for CYP is not in line for a company at this level of development (ie non-clinical) and they are insufficiently capitalised for real clinical development. If you get "basic" and look at multiples (as a manufacturing technology company) they are trading at ~1,500 revenue, which is stupid.
Personally I am always wary of biotech companies that do reverse-mergers. Not all, but some. They often circumvent underwriter diligence for a reason. Not saying that this is the case here... But...
MSC V MPC, page-14
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.91M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.0¢ | 21.0¢ | $24.71K | 115.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 33964 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 2000 | 1 |
View Market Depth
| Last trade - 15.41pm 09/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |